A. Jenkins

Progression from first symptom to diagnosis in childhood brain tumours

Sophie Wilne, Jacqueline Collier, Colin Kennedy et al. · European Journal of Pediatrics · 2011 · 87 citations

Medicine, Oncology, Pediatrics +13

A phase II study of interferon‐α, interleukin‐2 and 5‐fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation

Johnathan Joffe, Rosamonde E. Banks, M A Forbes et al. · British Journal of Urology · 1996 · 78 citations

Medicine, Oncology, Pharmacology +17

Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients

Guillaume Ploussard, Hendrik Isbarn, Alberto Briganti et al. · Urologic Oncology Seminars and Original Investigations · 2014 · 74 citations

Medicine, Oncology, Urology +17

Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters

Dorine Bresters, Ánita Lawitschka, Chiara Cugno et al. · Bone Marrow Transplantation · 2016 · 43 citations · Full text

Medicine, Immunology, Oncology +11

Comparison of self-reported late effects with medical records among survivors of childhood cancer

Naomi Taylor, Kate Absolom, Gisela Michel et al. · European Journal of Cancer · 2010 · 23 citations

Medicine, Child Health, Oncology +15